Analysis | Metabolite Name | Measured Value | Units | Age Group | Sex | Smoking Status | Diagnosis |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | isothreitol | 80 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 86 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | isothreitol | 95 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | isothreitol | 102 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 107 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 111 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 120 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 122 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 124 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 128 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 131 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 142 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 142 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 146 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 150 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 152 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 157 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 159 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 160 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 165 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 166 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | isothreitol | 168 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 170 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 172 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 172 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | isothreitol | 176 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 176 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 177 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 177 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 180 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 183 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 184 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 184 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | isothreitol | 188 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 190 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 194 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 197 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 200 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 201 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 202 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 203 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | isothreitol | 206 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 206 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 207 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 210 | Counts | 60-64 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 211 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 212 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 213 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 214 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 215 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 218 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 218 | Counts | 50-54 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 219 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | isothreitol | 220 | Counts | 55-59 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 222 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 224 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 226 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | isothreitol | 227 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | isothreitol | 228 | Counts | 50-54 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 228 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 228 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 229 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 230 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 230 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 231 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 233 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 234 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 235 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 235 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 235 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 236 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 237 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 239 | Counts | 45-49 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 240 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 241 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 241 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 244 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 248 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 249 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 249 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 249 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 252 | Counts | 50-54 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 253 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 254 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 254 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 256 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 257 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 260 | Counts | 65-69 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 261 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 262 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 262 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 263 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 265 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 266 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 267 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 267 | Counts | 65-69 | Female | Former | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 268 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 268 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 271 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 271 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 273 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 275 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 277 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 277 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | isothreitol | 277 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | isothreitol | 279 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 279 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 282 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 282 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 284 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 284 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 285 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 285 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 285 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 286 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 288 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 288 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 288 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 290 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 291 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 291 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 292 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 292 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 293 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 293 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 294 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 297 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 298 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 298 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 299 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 300 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 302 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 302 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 303 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 304 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 304 | Counts | 65-69 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 307 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 309 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 311 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 312 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 312 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 312 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | isothreitol | 312 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 313 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 313 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 316 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | isothreitol | 317 | Counts | 70-74 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 318 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 319 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 319 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 322 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 322 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 323 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 324 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 324 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 324 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 325 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 326 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 326 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 327 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 327 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 328 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 330 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 331 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 332 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 334 | Counts | 60-64 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 334 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 335 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 336 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 336 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 337 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 337 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 337 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 338 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 339 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 340 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 341 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 341 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 345 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 346 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 349 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 353 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 354 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 355 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 356 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 357 | Counts | 55-59 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | isothreitol | 357 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 360 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | isothreitol | 363 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 366 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 367 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 368 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 368 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 370 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 370 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 374 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | isothreitol | 375 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | isothreitol | 377 | Counts | 60-64 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | isothreitol | 377 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | isothreitol | 378 | Counts | 65-69 | Male | Former | Other NSCLC |
Return to search page